LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $279 | -12.3% | 4,650 | +5.6% | 0.00% | 0.0% |
| Q2 2023 | $318 | -17.0% | 4,404 | -15.4% | 0.00% | -33.3% |
| Q1 2023 | $383 | +89.6% | 5,204 | +72.0% | 0.00% | +200.0% |
| Q4 2022 | $202 | -100.0% | 3,025 | -45.3% | 0.00% | -66.7% |
| Q3 2022 | $476,000 | +100.0% | 5,528 | +107.7% | 0.00% | +50.0% |
| Q2 2022 | $238,000 | -38.3% | 2,662 | -22.5% | 0.00% | 0.0% |
| Q1 2022 | $386,000 | -23.7% | 3,433 | +4.8% | 0.00% | 0.0% |
| Q4 2021 | $506,000 | +50.6% | 3,276 | +35.7% | 0.00% | 0.0% |
| Q3 2021 | $336,000 | +20.0% | 2,414 | +13.0% | 0.00% | 0.0% |
| Q2 2021 | $280,000 | +0.7% | 2,137 | +17.2% | 0.00% | 0.0% |
| Q1 2021 | $278,000 | -59.7% | 1,823 | -27.4% | 0.00% | -60.0% |
| Q3 2018 | $689,000 | -22.3% | 2,510 | -41.4% | 0.01% | -16.7% |
| Q2 2018 | $887,000 | +14.7% | 4,281 | -8.5% | 0.01% | +20.0% |
| Q1 2018 | $773,000 | -21.0% | 4,680 | -34.5% | 0.01% | -28.6% |
| Q4 2017 | $978,000 | +314.4% | 7,143 | +311.2% | 0.01% | +600.0% |
| Q3 2017 | $236,000 | +16.3% | 1,737 | +3.9% | 0.00% | 0.0% |
| Q2 2017 | $203,000 | -9.8% | 1,672 | -24.2% | 0.00% | -50.0% |
| Q3 2016 | $225,000 | -32.4% | 2,207 | -20.9% | 0.00% | 0.0% |
| Q2 2016 | $333,000 | +41.7% | 2,790 | +27.2% | 0.00% | 0.0% |
| Q1 2016 | $235,000 | +31.3% | 2,193 | +33.1% | 0.00% | +100.0% |
| Q4 2015 | $179,000 | -3.8% | 1,648 | -24.1% | 0.00% | 0.0% |
| Q3 2015 | $186,000 | +169.6% | 2,171 | +218.3% | 0.00% | 0.0% |
| Q2 2015 | $69,000 | -91.5% | 682 | -93.5% | 0.00% | -83.3% |
| Q1 2015 | $812,000 | +2800.0% | 10,530 | +1890.5% | 0.01% | – |
| Q4 2014 | $28,000 | 0.0% | 529 | -10.5% | 0.00% | – |
| Q3 2014 | $28,000 | -31.7% | 591 | -10.2% | 0.00% | – |
| Q2 2014 | $41,000 | -6.8% | 658 | 0.0% | 0.00% | – |
| Q1 2014 | $44,000 | +22.2% | 658 | -4.2% | 0.00% | – |
| Q4 2013 | $36,000 | -62.1% | 687 | -68.7% | 0.00% | -100.0% |
| Q3 2013 | $95,000 | +106.5% | 2,192 | +79.1% | 0.00% | – |
| Q2 2013 | $46,000 | – | 1,224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |